Caduet in an Untreated Subject Population
Public ClinicalTrials.gov record NCT00332761. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An 8-Week Randomized, Double-Blind, Placebo-Controlled Trial Examining The Efficacy And Safety Of Caduet® In Simultaneously Achieving Blood Pressure And Lipid Goals In An Untreated Hypertensive And Dyslipidemic Subject Population. (CUSP - Caduet in Untreated Subject Population)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine if Caduet will lower blood pressure to \<140/90 mmHg and lower LDL Cholesterol to \<100 mg/dL in subjects with hypertension and dyslipidemia who are not currently being treated for these medical conditions.
Study identification
- NCT ID
- NCT00332761
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 220 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 21 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2006 (Type not available)
- Primary completion
- Not listed
- Completion
- Sep 2007 (Actual)
- Last update posted
- Jan 27, 2021
2006 – 2007
United States locations
- U.S. sites
- 34
- U.S. states
- 17
- U.S. cities
- 33
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Jonesboro | Arkansas | 72401 | — |
| Pfizer Investigational Site | Little Rock | Arkansas | 72204 | — |
| Pfizer Investigational Site | Garden Grove | California | 92843 | — |
| Pfizer Investigational Site | Long Beach | California | 90806 | — |
| Pfizer Investigational Site | Tustin | California | 92780 | — |
| Pfizer Investigational Site | Aventura | Florida | 33180 | — |
| Pfizer Investigational Site | Fort Lauderdale | Florida | 33308 | — |
| Pfizer Investigational Site | Miami | Florida | 33137 | — |
| Pfizer Investigational Site | Pembroke Pines | Florida | 33027 | — |
| Pfizer Investigational Site | Atlanta | Georgia | 30309 | — |
| Pfizer Investigational Site | Decatur | Georgia | 30033 | — |
| Pfizer Investigational Site | Bossier City | Louisiana | 71111 | — |
| Pfizer Investigational Site | Fair Haven | Michigan | 48023 | — |
| Pfizer Investigational Site | Livonia | Michigan | 48152 | — |
| Pfizer Investigational Site | Jackson | Mississippi | 39201 | — |
| Pfizer Investigational Site | Jackson | Mississippi | 39202 | — |
| Pfizer Investigational Site | Excelsior Springs | Missouri | 64024 | — |
| Pfizer Investigational Site | Berlin | New Jersey | 08009 | — |
| Pfizer Investigational Site | Elizabeth | New Jersey | 07202 | — |
| Pfizer Investigational Site | Princeton | New Jersey | 08540 | — |
| Pfizer Investigational Site | South Bound Brook | New Jersey | 08880 | — |
| Pfizer Investigational Site | Binghamton | New York | 13901 | — |
| Pfizer Investigational Site | Monroe | North Carolina | 28112 | — |
| Pfizer Investigational Site | Winston-Salem | North Carolina | 27103 | — |
| Pfizer Investigational Site | Cincinnati | Ohio | 45236 | — |
| Pfizer Investigational Site | Dayton | Ohio | 45406-5144 | — |
| Pfizer Investigational Site | Eugene | Oregon | 97404 | — |
| Pfizer Investigational Site | Bensalem | Pennsylvania | 19020 | — |
| Pfizer Investigational Site | Kingsport | Tennessee | 37660 | — |
| Pfizer Investigational Site | Beaumont | Texas | 77702 | — |
| Pfizer Investigational Site | Colleyville | Texas | 76034 | — |
| Pfizer Investigational Site | Houston | Texas | 77030 | — |
| Pfizer Investigational Site | Temple | Texas | 76502 | — |
| Pfizer Investigational Site | Norfolk | Virginia | 23510 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00332761, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 27, 2021 · Synced Oct 16, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00332761 live on ClinicalTrials.gov.